 Telegraph.co.uk | Mepolizumab almost halves exacerbations in patients with severe asthma Medical Xpress After a year of treatment, the rate of clinically significant exacerbations—defined as episodes requiring oral corticosteroids, admission or visit to emergency department—in the mepolizumab groups was around half that of the placebo group (1.24, 1.46 ... GSK drug halves attacks in hard-to-treat asthma New asthma drug can cut hospital admissions by half: study |
